1008-88-4 | 3-Phenylpyridine

Packsize	Purity	Availability	Price	Discounted Price
1g	94%	in stock	$15.00	$10.00
5g	98%	in stock	$45.00	$32.00
25g	98%	in stock	$175.00	$123.00
100g	98%	in stock	$561.00	$393.00

Description

• Catalog Number: AA03590
• Chemical Name: 3-Phenylpyridine
• CAS Number: 1008-88-4
• Molecular Formula: C11H9N
• Molecular Weight: 155.1959
• MDL Number: MFCD00006380
• SMILES: c1ccc(cc1)c1cccnc1

Computed Properties

• Complexity: 127
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 12
• Hydrogen Bond Acceptor Count: 1
• Rotatable Bond Count: 1
• XLogP3: 2.5

Literature

• Development of pyridine dicoumarols as potent anti HIV-1 leads, targeting HIV-1 associated topoisomeraseIIβ kinase.

  Future medicinal chemistry 20170901

• Synthesis of functionalized cinnamaldehyde derivatives by an oxidative Heck reaction and their use as starting materials for preparation of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors.

  The Journal of organic chemistry 20111104

• Poly[(μ(2)-1,3-di-4-pyridyl-propane)(μ(3)-1,3-phenyl-enediacetato)-cadmium].

  Acta crystallographica. Section E, Structure reports online 20111101

• Novel agents for anti-platelet therapy.

  Journal of hematology & oncology 20110101

• Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathways.

  Synapse (New York, N.Y.) 20100301

• 3-Phenyl-pyridinium tetra-chlorido-aurate(III).

  Acta crystallographica. Section E, Structure reports online 20100301

• Fluorescent chemosensors for toxic organophosphorus pesticides: a review.

  Sensors (Basel, Switzerland) 20100101

• Emerging antiplatelet agents, differential pharmacology, and clinical utility.

  Journal of blood medicine 20100101

• Potent biphenyl- and 3-phenyl pyridine-based inhibitors of acetyl-CoA carboxylase.

  Bioorganic & medicinal chemistry letters 20091015

• SCH 530348: a novel oral thrombin receptor antagonist.

  Future cardiology 20090901

• 1H, 13C and 15N nuclear magnetic resonance coordination shifts in Au(III), Pd(II) and Pt(II) chloride complexes with phenylpyridines.

  Magnetic resonance in chemistry : MRC 20090801

• Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.

  Journal of medicinal chemistry 20080828

• Novel substituted (pyridin-3-yl)phenyloxazolidinones: antibacterial agents with reduced activity against monoamine oxidase A and increased solubility.

  Journal of medicinal chemistry 20071004

• Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors.

  Bioorganic & medicinal chemistry letters 20070901

• Biarylaniline phenethanolamines as potent and selective beta3 adrenergic receptor agonists.

  Journal of medicinal chemistry 20060504

• Metal-directed self-assembly of cavitand frameworks.

  The Journal of organic chemistry 20060331

• Blue-to-green electrophosphorescence of iridium-based cyclometallated materials.

  Chemical communications (Cambridge, England) 20051007

• Chemistry of a Ni(II) acetohydroxamic acid complex: formation, reactivity with water, and attempted preparation of zinc and cobalt analogues.

  Inorganic chemistry 20051003

• Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.

  Journal of medicinal chemistry 20010301